Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of Alzheimer's Disease (AD). This landmark study is focused on validating the novel awAIr™-Cerebral Amyloid Status (CAS) test, an innovative tool intended to provide physicians with definitive information about Alzheimer's pathology, enabling improved management of cognitive impairments....
India’s first Ethos Linear Accelerator in combination with surface guided radiotherapy for cancer patients...
The wearable ultrasound imaging solution combines the wireless freedom of Clarius ultrasound with the security of the ProbeFix Dynamic, enabling limitless research opportunities of bodies in motion....
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms. With more than 80% of people who need a pacemaker requiring pacing in two chambers of the heart (both the right atrium and right ventricle), the approval significantly increases access to leadless pacing for millions of people across the U.S.[i]...
Recent study conducted by Seoul National University Hospital provides strong evidence that high-accuracy AI model improves radiologists' chest X-ray analysis performance...
Group Management Services (GMS), a leading professional employer organization (PEO) headquartered in Richfield, Ohio, is pleased to announce its partnership with Lumina Imaging and Diagnostics. This collaboration revolutionizes the health care landscape for GMS clients and their employees throughout Northeast Ohio....
Proposed benefit category assignment represents a positive step in facilitating Medicare coverage of personal exoskeletons for qualified individuals with spinal cord injury (SCI)....
Long-term License Agreement Creates Bundled Solutions ...
Australians could benefit from better cancer treatments, new vaccines, depression treatment without medication, and deeper insights into gut health because of new medical research projects funded by the Albanese Government....
Techsomed Ltd., the developer of BioTrace, an AI powered software platform for real time ablation zone imaging and treatment precision enhancement....
![[L-R]: Ms. Vivien Tan, XP Business Manager, Siemens Healthineers ASEAN; Prof. Dr. dr. Lina Choridah, Sp.Rad (K), Chairwoman Indonesian Woman Imaging Society; Hendya Perbangkara, Head of Diagnostic Imaging, Siemens Healthineers Indonesia](/uploads/articles/l_r__ms_vivien_tan_xp_business_manager_siemens_healthineers_asean-24188.jpg)
